LinkedIn Profile

Access Acorda Therapeutics historical Linkedin company profile data on number of followers, employee headcount and more

Rows

Open dataset
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal Headcount change in past 24 months Company Name Sector Industry
nasdaq:acor 30583 Apr 14th, 2024 12:00AM Acorda Therapeutics, Inc. 13K 284.00 Open Apr 13th, 2024 10:29PM Apr 13th, 2024 10:29PM Acorda Therapeutics is a publicly traded (NASDAQ: ACOR) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. We started our company in 1995 as a network of scientists, physicians and business people with a common belief that sharing ideas and information could lead to innovative medical advances for people with neurological disorders. We have since evolved into a commercial-stage biotechnology company, successfully developing and commercializing important therapies that advance the care of people affected by neurological conditions. We achieve our goals by: • investing in research and development • collaborating closely with the patient, medical and scientific communities • retaining employees with compassion and commitment Acorda has been voted one of the best companies to work for in New York for the past five years in a row, as a result of our dynamic environment, strong corporate culture, significant emphasis on research and development, and a robust product pipeline. We are positioned to be an industry leader, poised for exceptional growth. See our community guidelines: http://acor.bio/acordasocial Open Developing and commercializing therapies that improve the lives of people with nervous system disorders, including multiple sclerosis (MS), spinal cord injury (SCI), stroke and epilepsy. Also developing a therapeutic approach for chronic heart failure. Open 2 Blue Hill Plaza Pearl River New York US 10965 Acorda Therapeutics Health Care Pharmaceuticals & Biotechnology
nasdaq:acor 30583 Apr 13th, 2024 12:00AM Acorda Therapeutics, Inc. 13K 284.00 Open Apr 12th, 2024 10:20PM Apr 13th, 2024 10:57AM Acorda Therapeutics is a publicly traded (NASDAQ: ACOR) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. We started our company in 1995 as a network of scientists, physicians and business people with a common belief that sharing ideas and information could lead to innovative medical advances for people with neurological disorders. We have since evolved into a commercial-stage biotechnology company, successfully developing and commercializing important therapies that advance the care of people affected by neurological conditions. We achieve our goals by: • investing in research and development • collaborating closely with the patient, medical and scientific communities • retaining employees with compassion and commitment Acorda has been voted one of the best companies to work for in New York for the past five years in a row, as a result of our dynamic environment, strong corporate culture, significant emphasis on research and development, and a robust product pipeline. We are positioned to be an industry leader, poised for exceptional growth. See our community guidelines: http://acor.bio/acordasocial Open Developing and commercializing therapies that improve the lives of people with nervous system disorders, including multiple sclerosis (MS), spinal cord injury (SCI), stroke and epilepsy. Also developing a therapeutic approach for chronic heart failure. Open 2 Blue Hill Plaza Pearl River New York US 10965 Acorda Therapeutics Health Care Pharmaceuticals & Biotechnology
nasdaq:acor 30583 Apr 12th, 2024 12:00AM Acorda Therapeutics, Inc. 13K 284.00 Open Apr 11th, 2024 10:23PM Apr 12th, 2024 07:52AM Acorda Therapeutics is a publicly traded (NASDAQ: ACOR) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. We started our company in 1995 as a network of scientists, physicians and business people with a common belief that sharing ideas and information could lead to innovative medical advances for people with neurological disorders. We have since evolved into a commercial-stage biotechnology company, successfully developing and commercializing important therapies that advance the care of people affected by neurological conditions. We achieve our goals by: • investing in research and development • collaborating closely with the patient, medical and scientific communities • retaining employees with compassion and commitment Acorda has been voted one of the best companies to work for in New York for the past five years in a row, as a result of our dynamic environment, strong corporate culture, significant emphasis on research and development, and a robust product pipeline. We are positioned to be an industry leader, poised for exceptional growth. See our community guidelines: http://acor.bio/acordasocial Open Developing and commercializing therapies that improve the lives of people with nervous system disorders, including multiple sclerosis (MS), spinal cord injury (SCI), stroke and epilepsy. Also developing a therapeutic approach for chronic heart failure. Open 2 Blue Hill Plaza Pearl River New York US 10965 Acorda Therapeutics Health Care Pharmaceuticals & Biotechnology
nasdaq:acor 30583 Apr 11th, 2024 12:00AM Acorda Therapeutics, Inc. 13K 284.00 Open Apr 10th, 2024 10:41PM Apr 11th, 2024 10:36AM Acorda Therapeutics is a publicly traded (NASDAQ: ACOR) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. We started our company in 1995 as a network of scientists, physicians and business people with a common belief that sharing ideas and information could lead to innovative medical advances for people with neurological disorders. We have since evolved into a commercial-stage biotechnology company, successfully developing and commercializing important therapies that advance the care of people affected by neurological conditions. We achieve our goals by: • investing in research and development • collaborating closely with the patient, medical and scientific communities • retaining employees with compassion and commitment Acorda has been voted one of the best companies to work for in New York for the past five years in a row, as a result of our dynamic environment, strong corporate culture, significant emphasis on research and development, and a robust product pipeline. We are positioned to be an industry leader, poised for exceptional growth. See our community guidelines: http://acor.bio/acordasocial Open Developing and commercializing therapies that improve the lives of people with nervous system disorders, including multiple sclerosis (MS), spinal cord injury (SCI), stroke and epilepsy. Also developing a therapeutic approach for chronic heart failure. Open 2 Blue Hill Plaza Pearl River New York US 10965 Acorda Therapeutics Health Care Pharmaceuticals & Biotechnology
nasdaq:acor 30583 Apr 10th, 2024 12:00AM Acorda Therapeutics, Inc. 13K 283.00 Open Apr 9th, 2024 10:27PM Apr 10th, 2024 04:45PM Acorda Therapeutics is a publicly traded (NASDAQ: ACOR) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. We started our company in 1995 as a network of scientists, physicians and business people with a common belief that sharing ideas and information could lead to innovative medical advances for people with neurological disorders. We have since evolved into a commercial-stage biotechnology company, successfully developing and commercializing important therapies that advance the care of people affected by neurological conditions. We achieve our goals by: • investing in research and development • collaborating closely with the patient, medical and scientific communities • retaining employees with compassion and commitment Acorda has been voted one of the best companies to work for in New York for the past five years in a row, as a result of our dynamic environment, strong corporate culture, significant emphasis on research and development, and a robust product pipeline. We are positioned to be an industry leader, poised for exceptional growth. See our community guidelines: http://acor.bio/acordasocial Open Developing and commercializing therapies that improve the lives of people with nervous system disorders, including multiple sclerosis (MS), spinal cord injury (SCI), stroke and epilepsy. Also developing a therapeutic approach for chronic heart failure. Open 2 Blue Hill Plaza Pearl River New York US 10965 Acorda Therapeutics Health Care Pharmaceuticals & Biotechnology
nasdaq:acor 30583 Apr 9th, 2024 12:00AM Acorda Therapeutics, Inc. 13K 283.00 Open Apr 8th, 2024 10:37PM Apr 9th, 2024 09:26AM Acorda Therapeutics is a publicly traded (NASDAQ: ACOR) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. We started our company in 1995 as a network of scientists, physicians and business people with a common belief that sharing ideas and information could lead to innovative medical advances for people with neurological disorders. We have since evolved into a commercial-stage biotechnology company, successfully developing and commercializing important therapies that advance the care of people affected by neurological conditions. We achieve our goals by: • investing in research and development • collaborating closely with the patient, medical and scientific communities • retaining employees with compassion and commitment Acorda has been voted one of the best companies to work for in New York for the past five years in a row, as a result of our dynamic environment, strong corporate culture, significant emphasis on research and development, and a robust product pipeline. We are positioned to be an industry leader, poised for exceptional growth. See our community guidelines: http://acor.bio/acordasocial Open Developing and commercializing therapies that improve the lives of people with nervous system disorders, including multiple sclerosis (MS), spinal cord injury (SCI), stroke and epilepsy. Also developing a therapeutic approach for chronic heart failure. Open 2 Blue Hill Plaza Pearl River New York US 10965 Acorda Therapeutics Health Care Pharmaceuticals & Biotechnology
nasdaq:acor 30583 Apr 8th, 2024 12:00AM Acorda Therapeutics, Inc. 13K 283.00 Open Apr 7th, 2024 10:44PM Apr 8th, 2024 06:24PM Acorda Therapeutics is a publicly traded (NASDAQ: ACOR) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. We started our company in 1995 as a network of scientists, physicians and business people with a common belief that sharing ideas and information could lead to innovative medical advances for people with neurological disorders. We have since evolved into a commercial-stage biotechnology company, successfully developing and commercializing important therapies that advance the care of people affected by neurological conditions. We achieve our goals by: • investing in research and development • collaborating closely with the patient, medical and scientific communities • retaining employees with compassion and commitment Acorda has been voted one of the best companies to work for in New York for the past five years in a row, as a result of our dynamic environment, strong corporate culture, significant emphasis on research and development, and a robust product pipeline. We are positioned to be an industry leader, poised for exceptional growth. See our community guidelines: http://acor.bio/acordasocial Open Developing and commercializing therapies that improve the lives of people with nervous system disorders, including multiple sclerosis (MS), spinal cord injury (SCI), stroke and epilepsy. Also developing a therapeutic approach for chronic heart failure. Open 2 Blue Hill Plaza Pearl River New York US 10965 Acorda Therapeutics Health Care Pharmaceuticals & Biotechnology
nasdaq:acor 30583 Apr 7th, 2024 12:00AM Acorda Therapeutics, Inc. 13K 285.00 Open Apr 6th, 2024 10:36PM Apr 6th, 2024 10:36PM Acorda Therapeutics is a publicly traded (NASDAQ: ACOR) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. We started our company in 1995 as a network of scientists, physicians and business people with a common belief that sharing ideas and information could lead to innovative medical advances for people with neurological disorders. We have since evolved into a commercial-stage biotechnology company, successfully developing and commercializing important therapies that advance the care of people affected by neurological conditions. We achieve our goals by: • investing in research and development • collaborating closely with the patient, medical and scientific communities • retaining employees with compassion and commitment Acorda has been voted one of the best companies to work for in New York for the past five years in a row, as a result of our dynamic environment, strong corporate culture, significant emphasis on research and development, and a robust product pipeline. We are positioned to be an industry leader, poised for exceptional growth. See our community guidelines: http://acor.bio/acordasocial Open Developing and commercializing therapies that improve the lives of people with nervous system disorders, including multiple sclerosis (MS), spinal cord injury (SCI), stroke and epilepsy. Also developing a therapeutic approach for chronic heart failure. Open 2 Blue Hill Plaza Pearl River New York US 10965 Acorda Therapeutics Health Care Pharmaceuticals & Biotechnology
nasdaq:acor 30583 Apr 6th, 2024 12:00AM Acorda Therapeutics, Inc. 13K 285.00 Open Apr 5th, 2024 10:35PM Apr 5th, 2024 10:35PM Acorda Therapeutics is a publicly traded (NASDAQ: ACOR) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. We started our company in 1995 as a network of scientists, physicians and business people with a common belief that sharing ideas and information could lead to innovative medical advances for people with neurological disorders. We have since evolved into a commercial-stage biotechnology company, successfully developing and commercializing important therapies that advance the care of people affected by neurological conditions. We achieve our goals by: • investing in research and development • collaborating closely with the patient, medical and scientific communities • retaining employees with compassion and commitment Acorda has been voted one of the best companies to work for in New York for the past five years in a row, as a result of our dynamic environment, strong corporate culture, significant emphasis on research and development, and a robust product pipeline. We are positioned to be an industry leader, poised for exceptional growth. See our community guidelines: http://acor.bio/acordasocial Open Developing and commercializing therapies that improve the lives of people with nervous system disorders, including multiple sclerosis (MS), spinal cord injury (SCI), stroke and epilepsy. Also developing a therapeutic approach for chronic heart failure. Open 2 Blue Hill Plaza Pearl River New York US 10965 Acorda Therapeutics Health Care Pharmaceuticals & Biotechnology
nasdaq:acor 30583 Apr 5th, 2024 12:00AM Acorda Therapeutics, Inc. 13K 285.00 Open Apr 4th, 2024 10:40PM Apr 4th, 2024 10:40PM Acorda Therapeutics is a publicly traded (NASDAQ: ACOR) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. We started our company in 1995 as a network of scientists, physicians and business people with a common belief that sharing ideas and information could lead to innovative medical advances for people with neurological disorders. We have since evolved into a commercial-stage biotechnology company, successfully developing and commercializing important therapies that advance the care of people affected by neurological conditions. We achieve our goals by: • investing in research and development • collaborating closely with the patient, medical and scientific communities • retaining employees with compassion and commitment Acorda has been voted one of the best companies to work for in New York for the past five years in a row, as a result of our dynamic environment, strong corporate culture, significant emphasis on research and development, and a robust product pipeline. We are positioned to be an industry leader, poised for exceptional growth. See our community guidelines: http://acor.bio/acordasocial Open Developing and commercializing therapies that improve the lives of people with nervous system disorders, including multiple sclerosis (MS), spinal cord injury (SCI), stroke and epilepsy. Also developing a therapeutic approach for chronic heart failure. Open 2 Blue Hill Plaza Pearl River New York US 10965 Acorda Therapeutics Health Care Pharmaceuticals & Biotechnology

Request a demo to view additional historical data, and much more.

Request Demo

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.